Telehealth Anxiety Prescribing: What Prescribers Can Do in New York

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can prescribe anxiety medications through telehealth — or you’re trying to understand the regulatory maze between states — you’re not alone. The short answer: yes, you can prescribe anxiety meds via telehealth in 2026, including controlled substances like benzodiazepines. But the details matter, especially when it comes to your provider type, state licensing, and federal regulations.

Here’s what you actually need to know to practice confidently and compliantly.

The Federal Telehealth Rules: What Changed and What’s Still in Play

For years, the Ryan Haight Act required at least one in-person visit before prescribing controlled substances. COVID-19 upended that. The DEA suspended this requirement in 2020, allowing providers to prescribe Schedule II-IV medications (including benzodiazepines for anxiety and stimulants for ADHD) entirely via telehealth.

Good news: this flexibility has been extended through December 2026. The DEA and HHS announced the extension in early 2026 after recognizing that over 7 million controlled substance prescriptions — many for anxiety and ADHD — were being managed safely via telemedicine. Ending the flexibility abruptly would have created a care cliff for patients who’ve been receiving treatment remotely for years.

What this means for you: As a psychiatrist or PMHNP, you can initiate and manage anxiety medications — SSRIs, SNRIs, buspirone, even benzodiazepines — entirely through video visits. No in-person exam required. You can start a patient on Lexapro or Xanax after a proper telehealth evaluation, adjust doses in follow-ups, and prescribe refills, all remotely.

The caveat: the DEA is working on permanent rules to replace these temporary flexibilities. Expect new regulations by late 2026 that will likely include some safeguards (possibly a special telemedicine DEA registration or periodic in-person requirements for certain meds). Stay tuned to DEA announcements, but for now, you’re operating under the extended emergency rules.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State Telehealth Prescribing Rules: Where It Gets Specific

Federal rules set the baseline, but states can add their own requirements. Most align with federal policy, but a few have carved out specific rules you need to know:

Florida

Florida explicitly allows telehealth prescribing of Schedule II controlled substances for psychiatric disorders. This means you can prescribe stimulants for comorbid ADHD or other psych conditions via telehealth. Benzodiazepines (Schedule IV) face no special telehealth restrictions.

The catch: if you’re practicing in Florida via an out-of-state telehealth registration (not a full Florida license), you cannot prescribe controlled substances remotely. You need full Florida licensure to write those scripts. Also, Florida mandates checking the state PDMP (E-FORCSE) before prescribing any controlled anxiety medication — telehealth or in-person.

Texas

Texas allows telehealth prescribing for psychiatric conditions, including anxiety, but prohibits using telemedicine to treat chronic pain with controlled substances. Anxiety treatment doesn’t fall under this restriction, so you’re clear to prescribe benzodiazepines or other anxiolytics remotely.

You must establish a valid patient-provider relationship via live audio-video before prescribing (no phone-only). Texas also requires checking the state PDMP (PMP Aware) before any controlled substance prescription.

California

California has no telehealth-specific restrictions beyond federal rules. You can prescribe anxiety medications — including controlled substances — via video visits as long as you conduct an appropriate patient evaluation. California’s telehealth payment parity law (AB 744) ensures insurers pay the same for virtual visits as in-person, which makes telepsychiatry financially viable.

New York

New York integrates telehealth into standard practice with no special prescribing limits. The state’s iSTOP PDMP must be checked before prescribing any controlled substance, every time — one of the strictest mandates in the country. New York also has strong telehealth parity laws ensuring equal insurance coverage for tele-mental health.

One Medicare wrinkle to watch: federal policy had proposed requiring an in-person visit within 6 months for tele-mental health services, but enforcement keeps getting delayed. As of 2026, you can still treat Medicare patients for anxiety entirely via telehealth without periodic in-person visits.

Pennsylvania and Illinois

Neither state has telehealth-specific prescribing prohibitions for mental health. You can manage anxiety medications via telemedicine following the same standards as in-person care. Both require PDMP checks for controlled substances (Pennsylvania’s ABC-MAP and Illinois’ PMP).

Illinois has strong telehealth parity laws, and Pennsylvania’s insurers generally reimburse telepsychiatry equivalently to in-person visits, though the state lacks a comprehensive telehealth statute.

Psychiatrist vs PMHNP Prescribing Authority: Understanding the Gap

Here’s where provider type makes a real difference.

Psychiatrists (MD/DO)

You have unrestricted authority to prescribe anxiety medications in all 50 states, period. No supervision required, no collaborative agreements, no schedule restrictions (beyond standard DEA rules). You can prescribe SSRIs, benzodiazepines, beta-blockers, even off-label medications for anxiety — all via telehealth if you’re licensed in that state.

PMHNPs (Psychiatric Nurse Practitioners)

Your prescribing authority depends on your state’s scope of practice laws, which fall into three categories:

Full Practice Authority (FPA) StatesIn states like New York, Arizona, Oregon, and Washington, PMHNPs can evaluate, diagnose, and prescribe medications — including controlled substances — completely independently. No physician oversight required.

New York just achieved this in 2022 when Governor Hochul signed the Nurse Practitioner Modernization Act, eliminating the prior collaborative agreement requirement. Now a New York PMHNP has essentially the same prescriptive authority as a psychiatrist for anxiety treatment.

Reduced Practice StatesThese states require a collaborative agreement with a physician for prescriptive authority, but NPs can work relatively independently day-to-day.

California is mid-transition: under AB 890 (effective 2023), experienced NPs can become ‘103 NPs’ and practice without standardized physician procedures in group settings. By January 2026, qualified NPs can apply to become ‘104 NPs’ with full independent practice including prescribing. Until then, most California PMHNPs still operate under physician protocols.

Illinois requires collaboration initially but allows Full Practice Authority after 4,000 clinical hours and 250 hours of continuing education. Even with FPA, Illinois NPs need a one-time physician sign-off to include benzodiazepines and Schedule II drugs in their scope.

Restricted Practice StatesStates like Texas, Florida, and Pennsylvania require ongoing physician supervision or collaboration for all NP prescribing.

Texas mandates a Prescriptive Authority Agreement with a physician and prohibits NPs from prescribing Schedule II controlled substances outside hospital/hospice settings. For anxiety, this means a Texas PMHNP can prescribe benzodiazepines (Schedule IV) but not stimulants for comorbid ADHD unless in a hospital setting.

Florida requires a written protocol with a supervising physician. Florida NPs face a 7-day limit on Schedule II prescriptions unless they’re a psychiatric NP treating mental illness — in which case they can prescribe longer supplies. Benzodiazepines are Schedule IV, so no special limits apply there beyond what’s in the collaborative protocol.

Pennsylvania requires a collaborative agreement with chart review requirements (physicians must review a percentage of NP charts, including 100% of Schedule II prescriptions within 24 hours).

The Bottom Line for NPs

If you’re a PMHNP in a Full Practice state, your anxiety prescribing authority matches a psychiatrist’s. In Reduced or Restricted states, you need a physician collaborator, and you may face limitations on certain controlled substances. This affects not just what you can prescribe, but where you can practice — if you can’t find a collaborating psychiatrist in a rural area, you legally can’t prescribe, leaving a care gap.

Telehealth platforms can help by either pairing you with collaborating physicians where required or focusing recruitment in states with favorable NP laws.

Reimbursement: What You’ll Actually Get Paid for Anxiety Medication Management

Understanding the economics matters when you’re deciding whether to join a telehealth platform or expand your practice.

Medicare Rates (2026)

Medicare pays well for psychiatric medication management:

• Initial psychiatric evaluation (90792): ~$202
• 15-minute med check follow-up (99213): ~$95
• 25-minute moderate complexity visit (99214): ~$136
• 30-minute psychotherapy add-on (90833): ~$81

These are national averages; some high-cost areas pay more. Medicare’s telehealth parity has been extended — you get paid the same for virtual visits as in-person through at least 2026.

Medicaid Rates

Medicaid pays significantly less — typically 50-60% of Medicare rates. For example:

• 90792 (initial eval): ~$85
• 99213 (med check): ~$40-50

Lower per-visit rates, but if you can see high volume with lower overhead via telehealth, the math can still work.

Private Insurance

Commercial payers typically reimburse at 100-150% of Medicare rates. Many states have telehealth parity laws requiring insurers to pay equally for virtual visits. California, Illinois, and New York have strong parity laws; Texas does not require it, though many insurers voluntarily pay equal rates for tele-mental health.

PMHNP Reimbursement Difference

Medicare and most insurers reimburse nurse practitioners at 85% of physician rates. A psychiatrist getting $100 for a med check means an NP gets $85 for the same service. Some states’ Medicaid programs pay NPs the same as MDs, but it varies.

Practically, this 15% difference affects platform economics and your earning potential, but it’s often offset by NPs’ lower salary requirements and high patient demand.

The Economics of Patient Acquisition: Why Platforms Make Sense

Let’s talk about the elephant in the room: acquiring patients is expensive and time-consuming when you do it yourself.

The Real Cost of DIY Marketing

Many providers underestimate what it actually costs to fill a practice:

SEO (Search Engine Optimization): Takes 6-12 months of consistent investment before generating meaningful patient flow. You need content, technical optimization, backlinks — most solo providers don’t have the expertise or patience. Budget $1,500-3,000/month for professional SEO with no guarantee of results in the short term.

Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. Factor in testing, optimization, and no-show rates from cold leads, and your cost per booked patient is realistically $200-400+. If even half don’t show up or aren’t a good fit, your actual cost per seen patient climbs higher.

Directory listings (Psychology Today, Zocdoc): You pay monthly fees ($30-100+) AND compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+) but you still need a monthly subscription. Total monthly costs add up quickly.

Total realistic DIY cost: $3,000-5,000/month in marketing spend, staff time to handle and qualify leads, months before ROI, and no guarantee of consistent patient flow.

How Telehealth Platforms Change the Math

Platforms like Klarity Health use a pay-per-appointment model. Instead of spending thousands upfront on marketing with uncertain results, you pay a standard listing fee when a qualified patient books with you.

The value proposition:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

Frame it this way: instead of gambling $3,000-5,000/month on marketing channels that might work eventually, you pay only when a qualified patient actually shows up for an appointment. That’s guaranteed ROI versus uncertain outcomes.

Yes, DIY marketing can eventually be cost-effective IF you have the budget, expertise, and patience to wait 6-12 months for results. But for most providers — especially those starting out, scaling up, or in underserved areas — a platform that handles patient acquisition removes all that risk.

The Provider Shortage Reality: High Demand, Limited Supply

Anxiety disorders are among the most common mental health conditions, and demand for psychiatric prescribers far exceeds supply in most states.

Consider the numbers:

• Texas: ~1 psychiatrist per 8,966 residents (well above the national ratio)
• Florida: ~1 psychiatrist per 8,577 residents
• Illinois: ~1 psychiatrist per 5,849 residents

These shortages, combined with rising anxiety cases post-pandemic, create enormous opportunity for providers willing to practice via telehealth. You can serve patients in underserved areas, work across state lines (with proper licensure), and fill a critical gap in mental health care.

Many states have licensure compacts or telehealth registrations to facilitate multi-state practice. Texas participates in the Interstate Medical Licensure Compact (IMLC), making it easier to get licensed in multiple states. Florida offers out-of-state telehealth provider registration, though you can’t prescribe controlled substances with just the registration.

Platforms that handle multi-state credentialing, billing, and patient matching let you focus on what you do best: treating patients.

What This Means for Your Practice

Whether you’re a psychiatrist with full independent authority or a PMHNP navigating state collaboration requirements, telehealth prescribing for anxiety is legally and financially viable in 2026.

Key takeaways:

• Federal telehealth flexibilities allow controlled substance prescribing through 2026 (with permanent rules coming)
• State laws vary — know your state’s specific rules and PDMP requirements
• Psychiatrists practice independently everywhere; PMHNPs face varying levels of oversight depending on state
• Reimbursement for medication management is solid, especially with Medicare and private insurance parity
• Patient acquisition costs are high and slow with DIY marketing; platforms offer guaranteed ROI by removing upfront risk
• Provider shortages create massive demand for telehealth psychiatric prescribers

If you’re considering joining a telehealth platform, the business case is clear: let someone else handle the expensive, uncertain work of marketing and patient acquisition while you focus on treating anxiety patients who need your expertise. You get consistent patient flow, predictable economics, and the ability to practice across state lines where demand is highest.

Ready to see how this works in practice? Platforms like Klarity Health connect psychiatric prescribers with pre-qualified patients seeking anxiety treatment — no marketing budget required, no wasted ad spend, just matched patients ready to book. You control your schedule, see patients via telehealth, and get paid for every appointment.

Frequently Asked Questions

Can psychiatrists prescribe benzodiazepines via telehealth in 2026?Yes. Federal telehealth flexibilities (extended through December 2026) allow psychiatrists to prescribe controlled substances including benzodiazepines entirely via video visits, with no in-person exam required. State PDMP checks are mandatory.

Do PMHNPs need a collaborating physician to prescribe anxiety medications?It depends on your state. In Full Practice Authority states (like New York, Arizona, Oregon), PMHNPs can prescribe independently. In Restricted states (like Texas, Florida, Pennsylvania), you need a collaborative agreement or supervision to prescribe, and some states limit NP authority for certain controlled substances.

What’s the difference between how California and Texas treat PMHNP prescribing?California is transitioning to allow experienced NPs (103/104 NP categories) to practice independently by 2026, removing physician supervision requirements. Texas requires all NPs to have a Prescriptive Authority Agreement with a physician and prohibits NP prescribing of Schedule II drugs outside hospital settings. California PMHNPs will soon have near-parity with psychiatrists; Texas PMHNPs remain significantly restricted.

How much does Medicare pay for a psychiatric medication management visit in 2026?Medicare pays approximately $95 for a 15-minute established patient visit (99213) and $202 for an initial psychiatric evaluation (90792). Telehealth visits are reimbursed at the same rate as in-person visits through 2026.

Can I prescribe anxiety medications to patients in other states via telehealth?Only if you’re licensed in that state. You must hold an active medical or nursing license in the state where the patient is located during the telehealth visit. Some states participate in licensure compacts (like IMLC for physicians) to streamline multi-state licensing.

What’s the real cost of acquiring a new psychiatric patient through marketing?When you factor in all costs — SEO investment (6-12 months before results), Google Ads ($15-40+ per click, $200-400+ per booked patient), directory fees, staff time to qualify leads, and no-show rates — you’re looking at $3,000-5,000/month in total marketing spend with uncertain ROI. Telehealth platforms eliminate this by using a pay-per-appointment model where you only pay when a qualified patient actually sees you.

Do I need to check a PDMP before prescribing benzodiazepines via telehealth?Yes. Virtually all states require checking the state Prescription Drug Monitoring Program (PDMP) before prescribing controlled substances, regardless of whether the visit is in-person or via telehealth. Some states (like New York) require PDMP checks for every controlled substance prescription with few exceptions.

Will the DEA telehealth flexibilities become permanent?The current flexibilities are temporary (extended through December 2026). The DEA is working on permanent regulations that will likely include some safeguards — possibly a special telemedicine DEA registration or modified exam requirements. Final rules are expected by late 2026.

References

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov) – Official government source on federal telehealth prescribing policy, January 2, 2026

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov) – State law text defining NP scope and telehealth rules in Florida, 2024 Statutes

3. California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov) – State regulatory guidance on new NP independent practice categories, updated 2024

4. NPNY announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com) – Professional association update on New York’s full practice authority for NPs, April 9, 2022

5. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (therathink.com) – Analysis of CMS data for psychiatric billing codes and Medicare rates, 2025/2026

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs